Home › Research › Risk factors
Trends in Alzheimer’s Disease Mortality in the Mississippi Delta, 2016–2022
Nafiseh Gavari, Jazmin Adjei, Yalanda M. Barner, Amal Krishna Mitra, Sheila Moore, Elizabeth A. Jones. Journal of dementia and Alzheimer's disease, 2025-11-27
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
From 2016 to 2022, Alzheimer’s disease mortality significantly increased among Black individuals (AAPC = 8.3%, 95% CI [2.6 to 16.0]; p < 0.05) and declined among White individuals (AAPC = −2.9%, 95% CI [−12.3 to 7.6] p < 0.05). Gender-specific analyses showed slight, non-significant increases among both males and females. County-level disparities were evident: counties such as Sharkey experienced increases exceeding 10%, while Humphreys counties showed declines. Racial disparities in AD mortality were more pronounced than gender differences. This study reveals widening racial and geographic disparities in Alzheimer’s disease mortality across the Mississippi Delta. The statistically significant increase among Black seniors highlights structural inequities in early diagnosis, access to culturally appropriate care, and chronic disease management. These findings support the need for targeted public health interventions, such as the expansion of rural memory clinics, culturally competent outreach, and Medicaid-supported long-term care. Strengthening surveillance systems like MSTAHRS is critical to tracking disparities and advancing equity in dementia-related mortality.
What this study adds
Evidence grade: Low
This study found that Alzheimer's disease mortality increased significantly among Black individuals and declined among White individuals in the Mississippi Delta from 2016 to 2022. Reported effect size: 8.3%; 2.9%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Gavari, N., Adjei, J., Barner, Y. M., Mitra, A. K., Moore, S., & Jones, E. A. (2025). Trends in Alzheimer’s Disease Mortality in the Mississippi Delta, 2016–2022. Journal of dementia and Alzheimer's disease. https://doi.org/10.3390/jdad2040044
Vancouver
Gavari N, Adjei J, Barner YM, Mitra AK, Moore S, Jones EA. Trends in Alzheimer’s Disease Mortality in the Mississippi Delta, 2016–2022. Journal of dementia and Alzheimer's disease. 2025. doi:10.3390/jdad2040044.
BibTeX
@article{gavari2025-65bf5c9b,
author = {Gavari, Nafiseh and Adjei, Jazmin and Barner, Yalanda M. and Mitra, Amal Krishna and Moore, Sheila and Jones, Elizabeth A.},
title = {{Trends in Alzheimer’s Disease Mortality in the Mississippi Delta, 2016–2022}},
journal = {Journal of dementia and Alzheimer's disease},
year = {2025},
doi = {10.3390/jdad2040044},
url = {https://doi.org/10.3390/jdad2040044}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- From 2016 to 2022, Alzheimer’s disease mortality significantly increased among Black individuals (AAPC = 8.3%, 95% CI [2.6 to 16.0]; p < 0.05) and declined among White individuals (AAPC = −2.9%, 95% CI [−12.3 to 7.6] p < 0.05).
- Gender-specific analyses showed slight, non-significant increases among both males and females.
- County-level disparities were evident: counties such as Sharkey experienced increases exceeding 10%, while Humphreys counties showed declines.
- Racial disparities in AD mortality were more pronounced than gender differences.
- This study reveals widening racial and geographic disparities in Alzheimer’s disease mortality across the Mississippi Delta.
Why it matters
This study found that Alzheimer's disease mortality increased significantly among Black individuals and declined among White individuals in the Mississippi Delta from 2016 to 2022. It describes disparities in death rates and does not test any treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Effect size8.3%; 2.9%
- Evidence strengthLow
How this study scored 30/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of dementia and Alzheimer's disease) |
| Journal's citation record | 0 / 4 | Journal of dementia and Alzheimer's disease: journal h-index 7 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Elizabeth A. Jones: h-index 34 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Texas Tech University: institution h-index 686 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 30 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3390/jdad2040044
- Original source →
- Free full text: Journal of dementia and Alzheimer's disease →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Risk factors from nearby years
Also in Risk factors
395 studies in the library are filed under Risk factors with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk factors hub.